Latest New York Toronto London Sydney

Want to know each day's companies with the most bullish news?

xAmplification - Company News in Context

Live

Showing results for:Ticker: DON

Alerts

GET EMAILED IMMEDIATELY NEW ARTICLES ARE PUBLISHED

Include the exchange (e.g. ASX:DEG, TSX:MAG, AIM:POW) and separate with commas

Filters

Market

Sector

Date Range

Sentiment

Ticker Symbol

Filtering: DON

Noelle· Any Questions?

© 2026 xAmplification. For informational purposes only. Not financial advice.

xAmplification - Company News in Context

7 articles · filtered by DON

US FDA approves Arexvy for adults 18-49 AIR

AIM:GSKLSE:DON|Bullish|13 Mar 2026 · about 19 hours ago

Results of Court Meeting and General Meeting

AIM:SPALSE:DON|Bullish|12 Mar 2026 · 1 day ago

GSK and Alfasigma agree global linerixibat rights

AIM:GSKLSE:DON|Bullish|9 Mar 2026 · 5 days ago

GSK completes acquisition of RAPT Therapeutics

AIM:GSKLSE:DON|Bullish|3 Mar 2026 · 11 days ago

Linerixibat accepted for priority review in China

AIM:GSKLSE:DON|Bullish|26 Feb 2026 · 16 days ago

Bepirovirsen accepted for Japan regulatory review

AIM:GSKLSE:DON|Bullish|26 Feb 2026 · 16 days ago

Annual results 2025 Zoom meeting

AIM:HSBALSE:DONLSE:OXB|Bullish|25 Feb 2026 · 17 days ago